Maplight Therapeutics, INC Form 4 insider transactions

MapLight Therapeutics, Inc. Director Timothy John Garnett was granted 6,294 restricted stock units and 25,604 employee stock options on October 27, 2025.

MapLight Therapeutics Director Maria C. Walker received restricted stock units and stock options as part of her compensation.

MapLight Therapeutics' General Counsel, Kristopher Hanson, received awards of 27,098 restricted stock units and options for 110,046 shares of common stock.

MapLight Therapeutics' CAAO and PAO, Jonathan Gillis, was granted 30,565 restricted stock units and 124,022 employee stock options.

MapLight Therapeutics' Chief Scientific Officer, James Woodruff Lillie, received 32,539 restricted stock units and options for 132,023 shares.

MapLight Therapeutics' Chief Discovery Officer, Anatol Kreitzer, received 35,953 restricted stock units and 146,052 employee stock options.